Can SELLAS Life Sciences (SLS) Stock Keep Its After-Hours Rally Going?

TLDR SELLAS stock rose 20% in after-hours trading Thursday after a regular session decline of 4.63%. The Phase 3 REGAL trial hit its 80th event, which set the final analysis in motion. The Q3 loss was $10.1 million, or $0.05 per share, in line with estimates. Cash climbed to $134.7 million from $71.8 million at [...]

The post Can SELLAS Life Sciences (SLS) Stock Keep Its After-Hours Rally Going? appeared first on Blockonomi.